Literature DB >> 10644837

Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus.

S Riegler1, H Hebart, H Einsele, P Brossart, G Jahn, C Sinzger.   

Abstract

The susceptibility of monocyte-derived immature dendritic cells (DC) to infection by various strains of human cytomegalovirus (HCMV) was analysed. Immature DC were generated by incubation of peripheral blood monocytes with interleukin-4 and granulocyte-macrophage colony-stimulating factor for 7 days and were characterized by a CD1a+/CD40+/CD80+/CD86+/HLA-DR+/CD14- phenotype. Viral antigen expression and production of infectious progeny virus were analysed in infected immature DC cultures. Immature DC were 80-90 % susceptible to HCMV strains that had been propagated in endothelial cell culture, whereas the infection rate was negligible with fibroblast-adapted HCMV strains. Immature DC infection resulted in expression of viral immediate early, early and late genes. Productive infection was proven by the detection of infectious virus in single-step growth curves and in infectious centre assays. It is concluded that HCMV might interfere with the host immune reaction by permissive, lytic infection of immature DC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644837     DOI: 10.1099/0022-1317-81-2-393

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  70 in total

1.  Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells.

Authors:  G Arrode; C Boccaccio; J Lulé; S Allart; N Moinard; J P Abastado; A Alam; C Davrinche
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.

Authors:  Laura Hertel; Vashti G Lacaille; Herbert Strobl; Elizabeth D Mellins; Edward S Mocarski
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

3.  RASCAL is a new human cytomegalovirus-encoded protein that localizes to the nuclear lamina and in cytoplasmic vesicles at late times postinfection.

Authors:  Matthew S Miller; Wendy E Furlong; Leesa Pennell; Marc Geadah; Laura Hertel
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

Review 4.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

5.  Epigenetic regulation of cellular and cytomegalovirus genes during myeloid cell development.

Authors:  Xue-Feng Liu; Mary Hummel; Michael Abecassis
Journal:  Intern Med Rev (Wash D C)       Date:  2017-03

Review 6.  Cytomegalovirus immune evasion of myeloid lineage cells.

Authors:  Melanie M Brinkmann; Franziska Dağ; Hartmut Hengel; Martin Messerle; Ulrich Kalinke; Luka Čičin-Šain
Journal:  Med Microbiol Immunol       Date:  2015-03-17       Impact factor: 3.402

7.  Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions.

Authors:  Sara Gredmark; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Inhibition of CD1 antigen presentation by human cytomegalovirus.

Authors:  Martin J Raftery; Manuel Hitzler; Florian Winau; Thomas Giese; Bodo Plachter; Stefan H E Kaufmann; Günther Schönrich
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

9.  Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

Authors:  Annalisa Macagno; Nadia L Bernasconi; Fabrizia Vanzetta; Erica Dander; Antonella Sarasini; Maria Grazia Revello; Giuseppe Gerna; Federica Sallusto; Antonio Lanzavecchia
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

10.  Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells.

Authors:  Nagendra R Hegde; David C Johnson
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.